HIGHFDA DEVICE

Summa Therapeutics Recalls 22 Finesse BTK Multicath Angioplasty Balloons Over Burst Specifications (

Summa Therapeutics recalled 22 units of the Finesse BTK Multicath Injectable Angioplasty Balloon Catheter sold to healthcare facilities in New Jersey and Florida. The balloon may not meet burst specifications, raising risk during angioplasty. Healthcare providers must stop using the device immediately and follow recall instructions from Summa Therapeutics.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
July 21, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
July 21, 2025
Hazard Level
HIGH
Brands
Finesse BTK Multicath, Summa Therapeutics
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Finesse BTK Multicath, Summa Therapeutics
Product type
Injectable Angioplasty Balloon Catheter
Model numbers
FS252251502, UDI-DI: 00810017490967
Sizes
5 French sheath, 0.014" guidewire compatible, Balloon diameter 2.5mm, Balloon length 225mm, Catheter working length 150cm
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    July 21, 2025

  2. Reported by FDA DEVICE

    April 8, 2026

  3. RecallRadar source check

    April 15, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Potential for the balloon in the device to not meet burst specifications.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact SUMMA THERAPEUTICS, LLC or your healthcare provider for instructions. Notification method: Letter

About This Product

This is an over-the-wire injectable angioplasty balloon catheter used in cardiovascular interventions. It features a 2.5mm balloon diameter, 225mm balloon length, and a 150cm working length, with a 5 French sheath and 0.014" guidewire compatibility.

Why This Is Dangerous

A balloon not meeting burst specifications can fail during inflation, potentially causing vessel injury or other complications requiring further intervention.

Industry Context

This recall is not presented as part of a broader industry pattern.

Real-World Impact

Hospitals and clinicians may need to pause procedures using this device pending replacement or refunds. The issue could cause procedure delays and additional costs for health facilities.

Practical Guidance

How to identify if yours is affected

  1. Verify device labeling for model FS252251502 and UDI-DI 00810017490967
  2. Check lot numbers 240502, 240095, 231296, 231296A, 240095A on packaging or device label
  3. Cross-check with recall notice to confirm if your units are affected

Where to find product info

Recall letter and FDA enforcement report provide identification details and remedy steps.

What timeline to expect

Remedies, including refunds or replacements, are expected to follow recall processing timelines typical for medical-device recalls (not specified in a

If the manufacturer is unresponsive

  • Document all contact attempts with Summa Therapeutics
  • If no response, escalate to hospital compliance and relevant regulatory bodies per local guidance

How to prevent similar issues

  • Implement strict inventory screening for model FS252251502 and UDI-DI 00810017490967
  • Verify device compatibility with 0.014" guidewires and 5 French sheath requirements before use
  • Monitor for any recall notices from Summa Therapeutics or FDA
  • Establish a recall response plan with clinical staff and supply chain

Documentation advice

Keep the recall letter, original packaging, labeling, and all correspondence with Summa Therapeutics; document lot numbers and device IDs for future audits.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model/Catalog Number: FS252251502; UDI-DI: 00810017490967; Lots: 240502, 240095, 231296, 231296A, 240095A. Sold to facilities in New Jersey and Florida. Sold date: Unknown. Price: Unknown. Quantity: 22 units. Recall date: 2025-07-21. Status: ACTIVE. Distributor: Summa Therapeutics.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • NJ and FL facilities affected

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
FS252251502
UDI-DI: 00810017490967
Affected States
ALL
Report Date
April 8, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more